Company / Interest Expense per Share
Taysha Gene Therapies, Inc. Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2023
5-year range
$0.04 / $0.06
FY2020-FY2023
Trend
+61.9%
vs FY2022
Sector context
#32 of 43
Health Care
What the data says
At $0.06, Taysha Gene Therapies, Inc.'s interest expense per share ranks #12 of 43 in the Health Care sector. Increased from $0.04 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2023 with a 3-year CAGR of +235.9%.
Increased from $0.04 to $0.06 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +235.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#12 of 43 in Health CareTop 26% of 43This company $0.06 Sector average $18.61
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 61.9% year-over-year.
- Ranks #32 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.06 | +61.9% |
| FY2022 | $0.04 | -2.1% |
| FY2021 | $0.04 | +2292.9% |
| FY2020 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026